Atlas Venture Fund Xi, L.P. Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

Atlas Venture Fund Xi, L.P. is > 10% Shareholder of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 6.01 Million shares of DAWN, which is worth approximately $76.8 Million. The most recent transaction as insider was on Dec 12, 2022, when has been sold 600,854 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.01M

0% 3M change

0% 12M change

Total Value Held $76.8 Million

Atlas Venture Fund XI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2022	SELL Other acquisition or disposition	-	600,854 Reduced 9.09%	6,008,534 Common Stock
Sep 19 2022	SELL Other acquisition or disposition	-	600,854 Reduced 8.33%	6,609,388 Common Stock
Nov 24 2021	SELL Other acquisition or disposition	-	801,138 Reduced 10.0%	7,210,242 Common Stock

Also insider at

DYN

Dyne Therapeutics, Inc. Healthcare

XLO

Xilio Therapeutics, Inc. Healthcare

> 10% Shareholder

IKNA

Ikena Oncology, Inc. Healthcare

> 10% Shareholder

THRD

Third Harmonic Bio, Inc. Healthcare

AVF